Oie Y, Nishida K. Regenerative medicine for the cornea. BioMed Res Int. 2013;2013 https://doi.org/10.1155/2013/428247.
Nosrati H, Abpeikar Z, Mahmoudian ZG, Zafari M, Majidi J, Alizadeh A, et al. Corneal epithelium tissue engineering: recent advances in regeneration and replacement of corneal surface. Regen Med. 2020;15(8):2029–44. https://doi.org/10.2217/rme-2019-0055.
Palchesko RN, Carrasquilla SD, Feinberg AW. Natural biomaterials for corneal tissue engineering, repair, and regeneration. Adv Healthc Mater. 2018;7(16):1701434. https://doi.org/10.1002/adhm.201701434.
Guérin L-P, Le-Bel G, Desjardins P, Couture C, Gillard E, Boisselier É, et al. The human tissue-engineered cornea (hTEC): recent progress. Int J Mol Sci. 2021;22(3):1291. https://doi.org/10.3390/ijms22031291.
Lagali N. Corneal stromal regeneration: current status and future therapeutic potential. Curr Eye Res. 2020;45(3):278–90. https://doi.org/10.1080/02713683.2019.1663874.
Vaidyanathan U, Hopping GC, Liu HY, Somani AN, Ronquillo YC, Hoopes PC, et al. Persistent corneal epithelial defects: a review article. Med Hypothesis Discov Innov Ophthalmol. 2019;8(3):163.
Bandeira F, Goh T-W, Setiawan M, Yam GH-F, Mehta JS. Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors. Stem Cell Res Ther. 2020;11(1):1–13. https://doi.org/10.1186/s13287-019-1533-1.
Feizi S. Corneal endothelial cell dysfunction: etiologies and management. Ther Adv Ophthalmol. 2018;10:2515841418815802. https://doi.org/10.1177/2515841418815802.
Colby K, Dana R. Foundations of corneal disease: past, present and future. Springer; 2019. https://doi.org/10.1007/978-3-030-25335-6.
Shang Q, Chu Y, Li Y, Han Y, Yu D, Liu R, et al. Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea. Cell Death Dis. 2020;11(8):1–15. https://doi.org/10.1038/s41419-020-02914-y.
Mathews PM, Lindsley K, Aldave AJ, Akpek EK. Etiology of global corneal blindness and current practices of corneal transplantation: a focused review. Cornea. 2018;37(9):1198–203. https://doi.org/10.1097/ICO.0000000000001666.
Singh R, Gupta N, Vanathi M, Tandon R. Corneal transplantation in the modern era. Indian J Med Res. 2019;150(1):7. https://doi.org/10.4103/ijmr.IJMR_141_19.
Antunes-Foschini R, Adriano L, Murashima AAB, Barbosa AP, Nominato LF, Dias LC, et al. Limitations and advances in new treatments and future perspectives of corneal blindness. Arq brasil oft. 2021;84:282–96. https://doi.org/10.5935/0004-2749.20210042.
Greenrod EB, Jones MN, Kaye S, Larkin DF, NHS B, Group TOTA. Center and surgeon effect on outcomes of endothelial keratoplasty versus penetrating keratoplasty in the United Kingdom. Am J Ophthalmol. 2014;158(5):957–66. e1. https://doi.org/10.1016/j.ajo.2014.07.037.
Ang M, Soh Y, Htoon HM, Mehta JS, Tan D. Five-year graft survival comparing Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2016;123(8):1646–52. https://doi.org/10.1016/j.ophtha.2016.04.049.
Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15(2):179–84. https://doi.org/10.1097/00003226-199603000-00011.
Lee WB, Shtein RM, Kaufman SC, Deng SX, Rosenblatt MI. Boston keratoprosthesis: outcomes and complications: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(7):1504–11. https://doi.org/10.1016/j.ophtha.2015.03.025.
Kao WW, Thomas VJC. Cell therapy of corneal diseases. Cornea. 2016;35(Suppl 1):S9. https://doi.org/10.1097/ICO.0000000000001010.
Chakrabarty K, Shetty R, Ghosh A. Corneal cell therapy: with iPSCs, it is no more a far-sight. Stem Cell Res Ther. 2018;9(1):1–15. https://doi.org/10.1186/s13287-018-1036-5.
Fuest M, Yam GH-F, Peh GS-L, Mehta JS. Advances in corneal cell therapy. Regen Med. 2016;11(6):601–15. https://doi.org/10.2217/rme-2016-0054.
Jirsova K, Jones GL. Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting—a review. Cell Tissue Bank. 2017;18(2):193–204. https://doi.org/10.1007/s10561-017-9618-5.
Schuerch K, Baeriswyl A, Frueh BE, Tappeiner C. Efficacy of amniotic membrane transplantation for the treatment of corneal ulcers. Cornea. 2020;39(4):479–83. https://doi.org/10.1097/ICO.0000000000002179.
Murri MS, Moshirfar M, Birdsong OC, Ronquillo YC, Ding Y, Hoopes PC. Amniotic membrane extract and eye drops: a review of literature and clinical application. Clin Ophthalmol. 2018;12:1105. https://doi.org/10.2147/OPTH.S165553.
Tseng SC. HC-HA/PTX3 purified from amniotic membrane as novel regenerative matrix: insight into relationship between inflammation and regeneration. Invest Ophthalmol Vis Sci. 2016;57(5):ORSFh1–8. https://doi.org/10.1167/iovs.15-17637.
Tseng SCG, Chen S-Y, Mead OG, Tighe S. Niche regulation of limbal epithelial stem cells: HC-HA/PTX3 as surrogate matrix niche. Exp Eye Res. 2020;199:108181. https://doi.org/10.1016/j.exer.2020.108181.
Ogawa Y, He H, Mukai S, Imada T, Nakamura S, Su CW, et al. Heavy chain-hyaluronan/pentraxin 3 from amniotic membrane suppresses inflammation and scarring in murine lacrimal gland and conjunctiva of chronic graft-versus-host disease. Sci Rep. 2017;7:42195. https://doi.org/10.1038/srep42195.
Khokhar S, Natung T, Sony P, Sharma N, Agarwal N, Vajpayee RB. Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea. 2005;24(6):654–60. https://doi.org/10.1097/01.ico.0000153102.19776.80.
Plummer CE. The use of amniotic membrane transplantation for ocular surface reconstruction: a review and series of 58 equine clinical cases (2002–2008). Vet Ophthalmol. 2009;12:17–24. https://doi.org/10.1111/j.1463-5224.2009.00741.x.
Hick S, Demers PE, Brunette I, La C, Mabon M, Duchesne B. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 2005;24(4):369–77. https://doi.org/10.1097/01.ico.0000151547.08113.d1.
Ke L, Shen D, Wang H, Qiao C, Zeng Q. Lamellar keratoplasty combined with amniotic membrane transplantation for the treatment of corneal perforations: a clinical and in vivo confocal microscopy study. BioMed Res Int. 2020;2020 https://doi.org/10.1155/2020/7403842.
Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol. 2001;119(2):298–300.
Fatima A, Sangwan V, Iftekhar G, Reddy P, Matalia H, Balasubramanian D, et al. Technique of cultivating limbal derived corneal epithelium on human amniotic membrane for clinical transplantation. J Postgrad Med. 2006;52(4):257.
Zhao Y, Ma L. Systematic review and meta-analysis on transplantation of ex vivo cultivated limbal epithelial stem cell on amniotic membrane in limbal stem cell deficiency. Cornea. 2015;34(5):592–600. https://doi.org/10.1097/ICO.0000000000000398.
Shanbhag SS, Hall L, Chodosh J, Saeed HN. Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2020;18(3):517–22. https://doi.org/10.1016/j.jtos.2020.03.004.
Suri K, Kosker M, Raber IM, Hammersmith KM, Nagra PK, Ayres BD, et al. Sutureless amniotic membrane ProKera for ocular surface disorders: short-term results. Eye Contact Lens. 2013;39(5):341–7. https://doi.org/10.1097/ICL.0b013e3182a2f8fa.
Mao Y, Protzman NM, John N, Kuehn A, Long D, Sivalenka R, et al. An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study. J Biomed Mater Res Part B Appl Biomater. 2023;111(3):684–700. https://doi.org/10.1002/jbm.b.35186.
Paul D. Luong, Edward S. Bennett, Stephanie L. Woo, Raymond J. Brill. The role of amniotic membrane transplantation. A look at the clinical efficacy of using AMs for ocular surface disorders and their utility in primary eye care. https://www.clspectrum.com/issues/2016/march-2016/the-role-of-amniotic-membrane-transplantation (2016).
Xanthopoulou PT, Elanwar M, Alzyadi M, Lavaris A, Kopsachilis N, Elanwar MFM, et al. Α novel sutureless pterygium excision surgery using human-derived dehydrated amniotic membrane. Cureus. 2022;14(4). https://doi.org/10.7759/cureus.23839.
Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014;4(2):111. https://doi.org/10.5500/wjt.v4.i2.111.
Polisetti N, Schmid A, Schlötzer-Schrehardt U, Maier P, Lang SJ, Steinberg T, et al. A decellularized human corneal scaffold for anterior corneal surface reconstruction. Sci Rep. 2021;11(1):1–15. https://doi.org/10.1038/s41598-021-82678-3.
Fernández-Pérez J, Ahearne M. Decellularization and recellularization of cornea: progress towards a donor alternative. Methods. 2020;171:86–96. https://doi.org/10.1016/j.ymeth.2019.05.009.
Isidan A, Liu S, Li P, Lashmet M, Smith LJ, Hara H, et al. Decellularization methods for developing porcine corneal xenografts and future perspectives. Xenotransplantation. 2019;26(6):e12564. https://doi.org/10.1111/xen.12564.
Shafiq MA, Gemeinhart RA, Yue BY, Djalilian AR. Decellularized human cornea for reconstructing the corneal epithelium and anterior stroma. Tissue Eng Part C Methods. 2012;18(5):340–8. https://doi.org/10.1089/ten.tec.2011.0072.
Wilson SL, Sidney LE, Dunphy SE, Dua HS, Hopkinson A. Corneal decellularization: a method of recycling unsuitable donor tissue for clinical translation? Curr Eye Res. 2016;41(6):769–82.
Comments (0)